IN ANALYZING the clinical and hemodynamic features of congestive heart failure due to myocardial disease or associated with mitral stenosis, many authors indicate or clearly imply that a significant augmentation in pulmonary blood volume plays a major role in the pathogenesis of pulmonary congestion and edema.'-6 These conclusions have depended largely upon indirect evidence such as clinical evaluation, the interpretation of chest roentgenograms, and the measurement of pulmonary vascular pressures and central blood volume.
Utilization of indicator-dilution techniques, combined with simultaneous right and transseptal left heart catheterization, has made more precise quantitation of the true pulmonary blood volume (PBV) possible. The technique of Milnor and associates7 has been employed in our laboratory in the study of several hundred patients with valvular and other forms of acquired heart disease.
It is the purpose of this presentation to (1) report the changes in PBV in a group of patients with heart failure associated with severe mitral stenosis and in another group of patients with nonvalvular congestive heart failure; (2) compare values of PBV in these patients with those obtained in a separate group of patients who had normal hemody- Methods Twenty-five patients between the ages of 14 and 57 years were studied. Twelve of these patients were studied hemodynamically because of a precordial systolic murmur which could not be evaluated with reasonable certainty by routine clinical investigations. This group included nine men and three women, between the ages of 14 and 45 years. None of these patients had hemodynamic abnormalities.
Thirteen patients were studied while in congestive heart failure. Six patients between the ages of 32 and 55 years were in heart failure secondary to mitral stenosis. Five of these six patients were women. Each patient had evidence of right ventricular decompensation.
Seven patients, all men between the ages of 28 and 57 years, were in congestive heart failure as a result of myocardial insufficiency. Five of the seven patients were in biventricular failure while the remaining two had manifestations of left-sided failure only. The diagnosis for six of the seven patients was thought to be nonobstructive cardiomyopathy. The seventh patient, J. McE., had documented rheumatic heart disease with severe aortic incompetence which had been successfully treated 4 months previously by prosthetic valve replacement.
Right heart and transseptal left heart catheterization were carried out in the manner described previously in detail.8 The left heart catheter was introduced into a saphenous vein or via a percutaneous femoral vein puncture. In most instances the left ventricle was entered. Left ventricular pressures were recorded at different levels of gain in order to facilitate measurement of left ventricular systolic and diastolic pressures.
Indicator-dilution curves were recorded after rapid successive injections of indocyanine green (Cardio-Green*) into the pulmonary artery (PA) *Hynson, Westcott and Dunning, Inc., Baltimore, Maryland. 249 and left atrium (LA) as previously described.7 Each curve was transcribed electronically onto IBM data cards which were fed into a previously programmed IBM Model 1620 computer for the determination of cardiac output and mean transit time. The programmed results and those obtained by manual computation were essentially identical.
The "central" blood volume (CBV) is that volume between the main pulmonary artery and the brachial artery, including all temporally equidistant branches. It was calculated by the Stewart-Hamilton method9 as follows: The pulmonary blood volume is that volume within the pulmonary arteries, pulmonary capillaries, pulmonary veins, and an indeterminant portion of the left atrium. It was calculated from the mean cardiac index and mean transit time from the main pulmonary artery to the left atrium as follows:
Where PBV = pulmonary blood volume (ml/ m2) Tm(LABA) = mean transit time in seconds from left atrium to brachial artery.
The mean distending or intravascular pressure in the pulmonary vessels and relative pulmonary vascular compliance was calculated as suggested by Milnor and associates.7 The former is the average of the pulmonary artery mean and left atrial mean pressures, while the latter, expressed in ml/m2/mm Hg, is the ratio of PBV to mean distending pressure.
Pulmonary vascular resistance was calculated as follows: PVR = PAM-LAM x K co Where: PVR = pulmonary vascular resistance in dynes' sec cm-5 PAm = pulmonary artery mean pressure in mm Hg LAm = left atrial mean pressure in mm Hg CO cardiac output in L/min K = conversion factor (1.36 X 60).
During a control period, pulmonary artery, left atrial, and brachial artery (BA) pressures were recorded along with the electrocardiogram. In most instances simultaneous left ventricular (LV) pressure was also recorded. The left heart catheter was then repositioned in the mid-left atrium. Minute ventilation and mixed expired air oxygen tension were continuously monitored to determine when a relatively steady state had been achieved. The PBV was then measured and simultaneous pressures were again recorded. Results
The pertinent data from the patients with normal hemodynamics are presented in table 1. Comparable hemodynamic data from the patients in cardiac failure are presented in table 2. Table 3 summarizes and compares the data obtained from all three groups.
Patients with Normal Hemodynamics
In the group of patients with normal hemodynamics the average cardiac index, heart rate, and stroke index were, respectively, as follows: 3.34 L/m,2 77 beats/min and 45 ml/m.2 The right atrial mean pressure varied between 1 and 5 mm Hg and the pulmonary artery mean pressure between 9 to 17 mm Hg. The left atrial mean pressure was 12 mm Hg or less in each patient. The average pulmonary intravascular distending pressure was 10.5 mm Hg. In no patient did the left ventricular end-diastolic pressure exceed 13 mm Hg. Small systolic pressure gradients from 4 to 10 mm Hg due to catheter movement were noted between the left ventricle and a systemic artery in five patients. Systemic artery pressures were within the normal range in all patients.
The mean central blood volume was 596 ml/m2 while the mean pulmonary blood volume was 271 ml/m. Of the six patients with severe mitral stenosis, five had clinical evidence of pulmonary congestion and right ventricular failure. The sixth patient, F.S., developed acute pulmonary edema during the catheterization procedure. Cardiac and stroke indices were severely compromised in each patient (means, 1.73 L/ min/m2 and 19.7 ml/beat/m,2 respectively). Right atrial mean pressure was significantly elevated and averaged 10.3 mm Hg. Marked elevation of both pulmonary artery and left atrial pressures was uniformly present. The left ventricular end-diastolic pressure, determined in only three patients, was less than 10 mm Hg in each. Systemic artery pressures were normal. The most surprising findings were seen in the values obtained for CBV and PBV. The former averaged 600 ml/m,2 while the latter averaged 238 ml/m.2 Both values did not differ significantly from those in the normal group. The mean relative pulmonary vascular compliance was reduced to less than one third of the normal value. Three patients had strikingly elevated pulmonary vascular resistances (707 to 2,245 dynes * sec cm-5), while in two patients moderate elevations were present. In one subject, M.P., the pulmonary vascular resistance was nearly normal.
Of particular interest are the data obtained in patient F.S. while she was in florid pulmonary edema. Although marked elevations in both pulmonary artery mean pressure and in left atrial mean pressure were present, the CBV and PBV were within normal limits, measuring 656 ml/m2 and 306 ml/M,2 respectively.
Among the seven patients with nonvalvular heart failure, subnormal cardiac indices (mean, 1.69 L/m2) and stroke indices (mean, 16 .9 ml/beat/m2) were present in each. The right atrial mean pressure was elevated in five of the seven patients and averaged 11.7 mm Hg. Significant elevation of both pulmonary artery and left atrial mean pressures was present in each patient. The former averaged 33.6 mm Hg while the latter averaged 25 For the group, relative pulmonary vascular compliance averaged 10.3 ml/m2/mm Hg which was less than one half the normal mean value. The mean pulmonary vascular resistance was 248 dynes-sec cm.-5 However, in three instances, it was normal, and in three it was moderately elevated. In only one patient did values for pulmonary vascular resistance exceed 480 dynes sec cm.-5
Discussion

Validation of the Method
The potential sources of error in this method of measuring PBV have been described in detail by Dock and associates'0 and in previous communications from this laboratory."' 12 Of particular concern is the problem of uneven blood flow through the lungs which may produce changes in both rate of blood flow and mean transit time as measured by the indicator-dilution method. For example, in the presence of heart disease, indicator which traverses an area of slow flow velocity may arrive tardily at the sampling site. This will prolong the downslope of the indicator-dilution curve and increase the Tm(PA BA) Thus, if cardiac output does not change, the CBV would be larger than if the indicator had traveled more rapidly through a normal pulmonary vascular bed.
Another problem would arise if the indicator injected into the pulmonary artery were lost from the circulation, as would occur if it escaped through pulmonary capillary walls, Circulation, Volume XXXIV, or if it returned to the systemic venous system through bronchopulxnonary venous anastomoses. The area under the dilution curve would be reduced. In this instance the cardiac output calculated from this curve would be larger than that derived from a left atrial injection of dye. If Tm(PA-BA) remained constant, the calculated CBV would again be larger.
The occurrence of either possibility would result in a larger calculated PBV since the volume of blood between the left atrium and the systemic artery would not be affected. Such possibilities would tend to minimize our results, not exaggerate them. Furthermore, if indicator were lost from the lungs during its primary circulation, one would expect to find a systematic difference in the measurement of blood flow derived from curves following pulmonary artery injection compared to those following left atrial injection. Such was not the case.
In contrast, if areas within the lung contain blood with such sluggish flow that it never mixes with the indicator, this fraction would not be included in the calculated CBV. This would produce a falsely low PBV. Whether or not such a hypothetical or pathophysiological state or both exist in the presence of chronic pulmonary venous hypertension is uncertain. Harris and Heath13 have described medial hypertrophy and intimal fibrosis of both pulmonary arteries and veins as characteristic lesions of pulmonary venous hypertension. In their experience, extensive and complex arterial "dilatation" lesions were not encountered. It would appear from the pathological findings of these authors and in the presence of high pulmonary artery pressure observed during hemodynamic studies, that the possibility of severe stagnation of the blood in the pulmonary vascular bed is probably not an important source of error.
The use of the computerized program in our study provided an added safeguard. Each indicator-dilution curve was scrutinized for stability of base line. Rigid limits were set in the program such that deviations of the base line greater than 3% of full-scale deflec-tion were rejected. Likewise, points used in the determination of the exponential downslope were accepted only if they deviated from a true exponential by less than 2% of the peak concentration value of the curve. The exponential downslope was determined from at least 5 points, and the best fit was calculated -by the computer using a least mean square fit. These criteria were fulfilled in all curves recorded from patients with normal hemodynamics as well as in all curves recorded from patients in heart failure in this study.
Furthermore, this method is sensitive enough to detect larger than "normal" PBVs in many patients with mitral stenosis of class III functional capacity.14
The Normal Pulmonary Blood Volume
Before adequate interpretation of PBV and CBV changes in patients with heart failure can be undertaken, the magnitude and variability of such measurements in normal subjects and in patients with normal hemodynamics must be assessed. In our 12 patients in the latter category, PBV averaged 271 ml/m2 (SE, 10.0) or 7.36 ml/kg of body weight, while CBV averaged 596 ml/m2 (SE, + 25.7). Few other studies of the PBV in relatively normal subjects are available in the literature. Dock and associates'0 investigated four patients with normal hemodynamics by utilizing simultaneous injections of two different indicators. The mean value for PBV was 246 ml/m2 (ranging from 219 to 269 ml/m2 ) and for CBV was 568 mI/M2 (ranging from 415 to 691 ml/m2). Five normal subjects were studied by McCaff and associates'5 employing sequential injections of indocyanine green. The mean value for PBV was 230 ml/m2 (SE, + 13.6) or 6.44 ml/kg of body weight.
Utilizing a single injection of indicator into the inferior vena cava followed by simultaneous sampling from the pulmonary artery and the left atrium, deFreitas and co-workers estimated PBV in 26 subjects of whom 21 were normal and five had systemic hypertension, As these authors mentioned, this technique for estimating PBV probably includes most of the left atrial volume as well. Control PBV determinations in 19 patients prior to polyvinylpyrrolidone infusion averaged 295 ml/m2 (SE, ± 16), while control PBV determinations in 14 patients prior to peripheral venous pooling averaged 277 ml/m2 (SE, + 22). 16 It would appear, therefore, that our average values for PBV and CBV in patients with normal hemodynamics are reasonable and within the range of error noted by others.
Criteria for Congestive Heart Failure
Crucial to the interpretation of the data in this study is the question of what constitutes congestive heart failure. It has been previously stressed that while overt signs and symptoms of heart failure are invariably accompanied by clear-cut hemodynamic derangements, the converse is not necessarily true.17 For example, following appropriate treatment, the clinical manifestations of cardiac decompensation may clear completely; yet underlying hemodynamic abnormalities may persist at rest or become manifest during mild exercise. 17 All five patients with mitral stenosis in heart failure had radiological evidence of pulmonary venous congestion with engorged vascular roots and interstitial edema. The sixth patient, F.S., was studied during an episode of acute pulmonary edema.
Among the seven patients with nonvalvular heart failure in this series, three (W.O'B.. G.D. and R.W.), presented all the clinical criteria of pulmonary congestion as well as clinical and hemodynamic criteria of biventricular failure. The criteria constituting evidence for heart failure in the four remaining patients were less complete, but still impressive. All of the hemodynamic criteria for cardiac decompensation were present, that is, very low minute and stroke output, moderate pulmonary hypertension, and marked elevations in left atrial and left ventricular enddiastolic pressures. However, none of the patients was orthopneic or had evidence of pulmonary edema by clinical or radiological examination. Despite this, the histories were Circulation, Volume XXXIV, ).5,AI compatible with recent heart failure, and all had various combinations of findings which indicated fluid retention and poor myocardial performance. These signs included tachycardia, narrowed pulse pressures, accentuated pulmonic closure, gallop rhythm, pulsus alternans, elevated venous pressure, and a positive hepatojugular reflux. In two of these patients (J.McE. and R.F.), acute digitalization resulted in dramatic decreases in left and right ventricular end-diastolic pressures and significant increases in cardiac index.
Pulmonary Blood Volume in Patients with Mitral
Stenosis in Heart Failure
While there has been a wide variability in the clinical material studied, patterns of hemodynamic alterations in mitral valve disease, particularly with respect to changes in PBV, have gradually evolved. Although Dock and associates'0 noted considerable overlap in values for PBV, they were able to correlate elevations in left atrial mean pressure with significant increases in PBV. They also noted that markedly elevated pulmonary vascular resistance was associated with smaller pulmonary blood volumes than would have been expected from the pressure-volume relationship seen in patients with low pulmonary vascular resistance. McGaff and co-workersl5 found appreciable increases in the PBV of patients with clinically and hemodynamically significant mitral stenosis, compared to values found in five normal subjects. Their observations were in agreement with those reported by Dock and associates.
On the other hand, Varnauskas and co-workers18 did not find a direct correlation between PBV and left atrial mean pressure. In their study, however, the mean value for PBV was 286 ml/m2 in three class IV patients with rheumatic heart disease involving the mitral valve.
Our own observations upon the variations in PBV in 74 patients with predominant mitral stenosis support and extend the studies of the aforementioned authors. These findings may be summarized as follows: (1) in patients of functional class I and II, the PBV Circulation, Volume XXXIV, August 1966 was within normal limits; (2) in patients of class III, significant elevations in mean PBV were encountered; and (3) in patients of class IV, the mean PBV was within the normal range. '4 In general, concordant changes in PBV and in pulmonary capillary blood volume (Vc) were noted in patients with mitral valve disease. Measurements in 56 patients with mitral valve lesions studied in our laboratory revealed that in class III patients both mean PBV and Vc were usually elevated, whereas in class IV patients both parameters were normal or reduced.19 Similar findings for Vc in patients with mitral valve disease have been reported by other workers.20 21 In the present study, Vc and PBV were determined in patient G.R. The values for each were significantly below normal, being 19.1 ml/m2 and 135 ml/m,2 respectively.
Resistance to flow in the pulmonary vascular bed may be controlled principally at a localized level such as the pulmonary arterioles.
As has been pointed out by Milnor and associates,7 this may have little effect upon the capacitance function of the pulmonary vascular bed which resides largely in the pulmonary capillary and venous systems. Thus, pulmonary vascular resistance and relative pulmonary vascular compliance need not necessarily be related. Data obtained by these investigators and by ourselves, however, indicate a highly significant inverse correlation between these two parameters.7 14 As a group, the patients with heart failure associated with mitral stenosis had the highest mean pulmonary vascular resistance and the lowest mean relative pulmonary vascular compliance.
In these patients, what is the mechanism by which the PBV and Vc remain normal or are reduced? It is well known that with chronic pulmonary venous hypertension, particularly that secondary to mitral stenosis. progressive changes occur within pulmonary blood vessels. Pathophysiological features of these alterations may be outlined as follows:'13 22 (1) medial hypertrophy, intimal proliferation, and fibrosis of pulmonary arteries and veins which increase with the dura-tion of pulmonary venous hypertension; (2) interstitial fibrosis, distention of pulmonary lymphatics, and increased lymphatic drainage from the lungs; (3) superimposition of thrombosis-in-situ and thromboembolism; and (4) redistribution of blood flow toward the upper lobes as a result of an increased lower lobe pulmonary vascular resistance associated with interstitial edema. 23 Functional vasoconstriction, related in an unknown manner to pulmonary venous hypertension, probably serves to initiate and perpetuate these pathological changes. As a result of these protracted pathophysiological changes, the pulmonary vascular bed becomes considerably restricted from within and without, and right ventricular failure supervenes. This condition is manifested by a decreased cardiac output, markedly elevated pulmonary artery and left atrial pressures, and a nearly normal or reduced PBV and Vc. Under such circumstances, one would expect to find reduced pulmonary vascular compliance and an elevated pulmonary vascular resistance.
Given these circumstances, stresses such as infection, fever, and tachyarrhythmias leading to clinical manifestations of acute pulmonary congestion apparently will result in an inordinate rise in pressure rather than a significant augmentation in PBV. Evidence that such is the case is provided by the six patients whose data are presented in this study. Worthy of reemphasis are the findings in patient F.S. who, while in acute pulmonary edema, had relatively normal PBV (306 ml/m2 ), but markedly elevated pulmonary artery and left atrial mean pressures (71 and 40 mm Hg, respectively). Further documentation of extreme pressure changes in patients with valvular heart disease studied during acute pulmonary edema is provided from the report of Finlayson and associates from this laboratory.24 In their six patients, the control pulmonary artery mean pressure was 57 mm Hg; during pulmonary edema, 76 mm Hg (three patients); and following recovery, 37 mm Hg (five patients). The pulmonary wedge pressure measured in two patients during pulmonary edema averaged 39 mm Hg.
Pulmonary Blood Volume in Patients with Nonvalvular Heart Failure
Correlative studies between right and left heart pressures, PBV and Vc have received scant attention in the past in these patients. In six of our seven patients in this group, the PBV and CBV were normal. Pulmonary artery hypertension in these patients was less marked than in the patients with mitral stenosis. In only two of the seven patients did the pulmonary vascular resistance exceed 240 dynessec cm.-5 Relative pulmonary vascular compliance was greater than in the mitral group. In two patients (S.C. and G.D.) in whom PBV and Ve were measured, both values were within the normal range.
How may normal PBV values be explained in these patients? While it is true that many of the pathological lesions noted in pulmonary venous hypertension secondary to left ventricular failure resemble those associated with severe mitral stenosis, the duration of symptoms in the former group of patients, however, was in terms of months rather than of years. Thus, it is reasonable to anticipate less conspicuous pathological changes within the pulmonary vasculature. However, this does not eliminate the possibilities of extravascular fluid accumulations, some interstitial fibrosis, and a significant reduction of flow to dependent portions of the lungs; nor can one be certain that the volume of the pulmonary vascular bed has not been compromised by thromboembolic phenomena.
Role of the PBV in Congestive Heart Failure
The data presented in this communication suggest that a revision of the classic concept of the pathogenesis of pulmonary congestion and edema is in order. The basic premise of previous interpretations of both the clinical and pathological manifestations of pulmonary congestion has been an increase in PBV. Our findings indicate, however, that such a change is not a sine qua non of either pulmonary congestion or edema in patients with chronic pulmonary venous hypertension. Since relative Circulation, Volume XXXIV, August 1966 2,d-)56 pulmonary vascu to at least one ha lieve that signific sure-volume char; vascular bed ha tients. These cha: sure-volume chare in figure 1 . Line i of pulmonary vas ent in the norm successive exercisi cise period no , pulmonary artery curred. When the greater work load pulmonary vascul While other datq are not available to the right, it i that it would bec a shape similar t volume curve ot nine lung studied that is, at larger on the basis of our present knowledge, be ing value for patients with heart construed as specifically related to an elevah mitral stenosis; ± mean resting tion in pulmonary vascular volume. We sugwith nonvalvular heart failure, A congestion are those which effect changes in pressure as well as those which alter the rate by which fluid can be transferred by this given pressure from the vascular to the extravascular compartment within the lung. Thus, one would predict that changes, if any, in PBV not accompanied by critical pressure elevations would not be associated with clinical features of pulmonary congestion. Such may well be the case in patients with high flow left-to-right shunts. On the other hand, provocative changes in pressure could induce congestive manifestations by the mechanisms postulated above without any significant alteration in intravascular volume. Volume changes, when observed, could thus reasonably be considered a secondary phenomenon, dependent upon the specific pressure-volume characteristics of the pulmonary vascular bed. Furthermore, this hypothesis implies that measures directed toward the treatment of pulmonary congestion and edema will be most effective if they result in a fall in pulmonary intravascular pressures.
Although the concepts presented here add complexity to the understanding of the pathogenesis of heart failure, they serve to emphasize the need for further investigation into the role of the pulmonary blood volume in congestive heart failure.
Summary
By utilizing indicator-dilution techniques, determinations of the pulmonary blood volume (PBV) and central blood volume (CBV) were made in 25 patients during simultaneous right and transseptal left heart catheterization. Of these, 12 patients had normal hemodynamics, six had heart failure associated with mitral stenosis, and seven had heart failure secondary to nonvalvular myocardial disease.
In the normal patients the PBV averaged 271 ml/m2 (SE, + 10.0) and the CBV 596 ml/m2 (SE, + 25.7). The mean value for PBV and CBV in the patients with heart failure associated with mitral stenosis was 238 mu/m2
(SE, ± 26.3) and 600 ml/m2 (SE, +40.9), respectively. Among the patients with nonvalvular heart failure the PBV averaged 292 ml/m2 (SE, ± 21.4) while the CBV averaged 679 ml/m2 (SE, + 45.8). In 12 of the 13 patients with heart failure, the individual values for PBV and CBV did not differ significantly from normal. However, in each of the 13 patients pulmonary artery, left atrial, and mean pulmonary distending pressures were significantly elevated, whereas the relative pulmonary vascular compliance was greatly reduced. These findings indicate that the pressurevolume relationships within the pulmonary vascular bed are greatly altered in the presence of chronic pulmonary venous hypertension. Normal values for PBV were associated with significant pressure elevations in the presence of pulmonary congestion and edema. It is concluded that in the pathogenesis of heart failure elevations in pulmonary vascular pressures play a dominant role while changes in PBV are of but secondary importance. These findings do not support many of the traditional concepts regarding the role of pulmonary blood volume changes in the pathophysiology of heart failure.
